High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasmsAnneli Enblom‐Larsson, Björn Andréasson, Emma Lindskog et al.|European Journal of Internal Medicine|2015Cited by 59
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022Jon Salmanton‐García, Summiya Nizamuddin, Sonia Martín‐Pérez et al.|EClinicalMedicine|2024Cited by 34
A retrospective analysis of the impact of treatments and blood counts on survival and the risk of vascular events during the course of polycythaemia veraAnneli Enblom‐Larsson, Björn Andréasson, François Girodon et al.|British Journal of Haematology|2017Cited by 14